• 1. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 2. An atomic scale study of defects in Co2FeAl
  Ravi Kumar Yadav,R. Govindaraj Phys. Chem. Chem. Phys., 2020,22, 26876-26886
• 3. An analysis of the WTC fires using CIB correlations and simple modeling
  JGQuintiere
• 4. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 5. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554

Recent Advances in the Study of 3-Fluoroquinolin-5-OL (CAS: 1261729-67-2): A Promising Scaffold in Medicinal Chemistry

3-Fluoroquinolin-5-OL (CAS: 1261729-67-2) has emerged as a significant scaffold in medicinal chemistry due to its versatile pharmacological properties. Recent studies have highlighted its potential as a key intermediate in the synthesis of novel therapeutic agents targeting various diseases, including cancer, infectious diseases, and neurological disorders. This research brief aims to provide an overview of the latest advancements in the study of 3-Fluoroquinolin-5-OL, focusing on its synthesis, biological activities, and potential applications in drug discovery.

The quinoline nucleus, a privileged structure in medicinal chemistry, has been extensively explored for its diverse biological activities. The introduction of a fluorine atom at the 3-position and a hydroxyl group at the 5-position of the quinoline ring (as in 3-Fluoroquinolin-5-OL) has been shown to enhance its pharmacological profile. Recent synthetic methodologies have enabled the efficient production of this compound, with improved yields and purity, making it more accessible for further biological evaluation.

In the context of anticancer research, 3-Fluoroquinolin-5-OL has demonstrated promising activity against various cancer cell lines. Mechanistic studies suggest that its antiproliferative effects are mediated through the inhibition of key enzymes involved in cell cycle regulation and apoptosis. For instance, a recent study published in the Journal of Medicinal Chemistry reported that derivatives of 3-Fluoroquinolin-5-OL exhibited potent inhibitory activity against topoisomerase II, a critical target in cancer therapy.

Beyond oncology, 3-Fluoroquinolin-5-OL has also shown potential in antimicrobial applications. Researchers have synthesized a series of derivatives with enhanced activity against drug-resistant bacterial strains, including methicillin-resistant Staphylococcus aureus (MRSA) and Mycobacterium tuberculosis. These findings underscore the compound's utility in addressing the global challenge of antimicrobial resistance.

In addition to its therapeutic potential, 3-Fluoroquinolin-5-OL has been investigated for its role in neuroprotection. Preliminary studies indicate that certain derivatives can modulate neurotransmitter systems and exhibit neuroprotective effects in models of neurodegenerative diseases such as Alzheimer's and Parkinson's. These results open new avenues for the development of neuroactive drugs based on the 3-Fluoroquinolin-5-OL scaffold.

Despite these promising findings, challenges remain in optimizing the pharmacokinetic and pharmacodynamic properties of 3-Fluoroquinolin-5-OL derivatives. Future research should focus on structure-activity relationship (SAR) studies to identify the most potent and selective analogs, as well as on improving their bioavailability and reducing potential toxicity.

In conclusion, 3-Fluoroquinolin-5-OL (CAS: 1261729-67-2) represents a valuable scaffold in medicinal chemistry with broad therapeutic potential. Continued research into its synthesis, biological activities, and applications will likely yield novel drug candidates for a range of diseases. This brief highlights the importance of this compound in current drug discovery efforts and underscores the need for further investigation to fully realize its potential.

• 260054-97-5(3,6-Difluoro-8-quinolinol)
• 1227579-28-3(1H-Indol-5-ol, 7-fluoro-)
• 209353-22-0(8-fluoroquinolin-6-ol)
• 426842-85-5(3-fluoro-6-methoxy-quinoline)
• 142363-59-5(3-fluoroquinolin-8-ol)
• 61293-17-2(6-Fluoro-4-methoxyquinoline)
• 288384-55-4(3-fluoroquinolin-7-ol)
• 808755-53-5(3-fluoroquinolin-6-ol)
• 1261784-49-9(8-Fluoroquinolin-3-ol)
• 887769-93-9(8-fluoro-5-methoxy-Quinoline)